Product NDC: | 55648-974 |
Proprietary Name: | DIVALPROEX SODIUM |
Non Proprietary Name: | DIVALPROEX SODIUM |
Active Ingredient(s): | 250 mg/1 & nbsp; DIVALPROEX SODIUM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55648-974 |
Labeler Name: | WOCKHARDT LIMITED |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077296 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080731 |
Package NDC: | 55648-974-01 |
Package Description: | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (55648-974-01) |
NDC Code | 55648-974-01 |
Proprietary Name | DIVALPROEX SODIUM |
Package Description | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (55648-974-01) |
Product NDC | 55648-974 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DIVALPROEX SODIUM |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20080731 |
Marketing Category Name | ANDA |
Labeler Name | WOCKHARDT LIMITED |
Substance Name | DIVALPROEX SODIUM |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |